Show simple item record

dc.contributor.authorLiang, Zhongjie
dc.contributor.authorLi, Lianchun
dc.contributor.authorWang, Yuanyuan
dc.contributor.authorChen, Limin
dc.contributor.authorKong, Xiangqian
dc.contributor.authorHong, Yao
dc.contributor.authorLan, Lefu
dc.contributor.authorZheng, Mingyue
dc.contributor.authorGuang-Yang, Cai
dc.contributor.authorLiu, Hong
dc.contributor.authorShen, Xu
dc.contributor.authorLuo, Cheng
dc.contributor.authorLi, Keqin Kathy
dc.contributor.authorChen, Kaixian
dc.contributor.authorJiang, Hualiang
dc.contributor.editorMei, Lin
dc.date.accessioned2012-10-26T16:29:29Z
dc.date.available2012-10-26T16:29:29Z
dc.date.issued2011-08-24en_US
dc.identifier.citationPLoS One. 2011 Aug 24; 6(8):e23606en_US
dc.identifier.issn1932-6203en_US
dc.identifier.pmid21887283en_US
dc.identifier.doi10.1371/journal.pone.0023606en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/671
dc.description.abstractThe New Delhi Metallo-b-lactamase (NDM-1) was first reported in 2009 in a Swedish patient. A recent study reported that Klebsiella pneumonia NDM-1 positive strain or Escherichia coli NDM-1 positive strain was highly resistant to all antibiotics tested except tigecycline and colistin. These can no longer be relied on to treat infections and therefore, NDM-1 now becomes potentially a major global health threat.
dc.rightsLiang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectResearch Articleen_US
dc.subjectBiologyen_US
dc.subjectBiophysicsen_US
dc.subjectBiomacromolecule-Ligand Interactionsen_US
dc.subjectBiophysics Simulationsen_US
dc.subjectComputational Biologyen_US
dc.subjectBiochemical Simulationsen_US
dc.subjectBiophysic Al Simulationsen_US
dc.subjectMacromolecular Structure Analysisen_US
dc.subjectSequence Analysisen_US
dc.subjectMicrobiologyen_US
dc.subjectBacterial Pathogensen_US
dc.subjectMicrobial Controlen_US
dc.subjectMicrobial Pathogensen_US
dc.subjectComputer Scienceen_US
dc.subjectComputer Modelingen_US
dc.titleMolecular Basis of NDM-1, a New Antibiotic Resistance Determinanten_US
dc.typeArticleen_US
dc.identifier.pmcidPMC3161043en_US
dc.contributor.corporatenameDepartment of Neurology
dc.contributor.corporatenameCollege of Graduate Studies
refterms.dateFOA2019-04-10T00:30:47Z
html.description.abstractThe New Delhi Metallo-b-lactamase (NDM-1) was first reported in 2009 in a Swedish patient. A recent study reported that Klebsiella pneumonia NDM-1 positive strain or Escherichia coli NDM-1 positive strain was highly resistant to all antibiotics tested except tigecycline and colistin. These can no longer be relied on to treat infections and therefore, NDM-1 now becomes potentially a major global health threat.


Files in this item

Thumbnail
Name:
pone.0023606.pdf
Size:
608.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record